News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Mary Hanley, LMSW

Advertisement

Articles by Mary Hanley, LMSW

Talking With Patients About Potential Cancer Misinformation

Talking With Patients About Potential Cancer Misinformation

By Mary Hanley, LMSW
January 5th 2023

Oncology nurses can help their patients navigate misinformation that they may find online.

Advertisement

Latest Updated Articles

  • Talking With Patients About Potential Cancer Misinformation
    Talking With Patients About Potential Cancer Misinformation

    Published: January 5th 2023 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML

2

Progression Occurs Early in R/R LBCL Treated With Epcoritamab, Glofitamab

3

Frontline Axi-Cel CR Linked With Improved Survival in High-Risk LBCL

4

Sacituzumab Govitecan Fails to Reach Significant PFS in HR+/HER2– mBC

5

Dexamethasone Reduces ICANS Severity in Axi-Cel in LBCL

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us